Jupiter Life Line Hospitals Limited

BSE: JLHL543980ISIN INE682M01020

Healthcare
Hospital
BSE 1000

BSE listing

Share price

₹280.15+2.80 (+1.01%)

as of 18 Sep 2026

52W high: ₹1,618.15
52W low: ₹271.25
Off 52W high: -82.69%
1M return: -12.81%
3M return: -79.13%
6M return: -77.86%
1Y return: -80.74%
20D avg volume: 43,277
50 DMA: ₹549.68
200 DMA: ₹1,127.77

Key ratios Consolidated

Market cap: ₹9,184 Cr
Current price: ₹280.15
52W high / low: ₹1,618.15 / ₹271.25
Face value: ₹2.00
P/E: 10.08
P/B: —
EPS (TTM): ₹28.41
Book value / share: —
ROE: —
ROCE: 13.80%
Operating margin: —
Net margin: —
Debt / equity: 0.33
Net debt: ₹453.77 Cr
Interest cover: 9.12
Dividend yield: 0.36%
Dividend / share (TTM): ₹1.00
Payout: 3.52%
Cash conversion cycle: 4.4 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	410.98	387.84	365.37	393.63	347.62	326.74	—
	10.59	9.15	9.13	11.27	12.87	7.03	—
	371.02	330.94	311.19	330.68	298.96	271.67	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	79.67	76.85	76.71	74.53	68.73	59.49	—
	74.45	67.72	63.65	63.25	59.44	53.80	—
	12.86	9.01	7.55	7.84	8.26	5.57	—
	26.44	23.26	21.70	21.46	21.20	17.62	—
	177.20	157.22	149.25	164.38	141.70	133.54	—
	50.55	66.05	63.31	74.22	61.53	62.09	—
	0.00	0.00	-6.40	0.00	0.00	0.00	—
	50.55	66.05	56.91	74.22	61.53	62.09	—
	13.04	17.29	14.41	16.75	17.66	17.22	—
	37.51	48.76	42.50	57.48	43.88	44.87	—
	5.72	7.66	6.49	8.75	6.69	6.84	—
Key metrics
	89.85	98.32	86.16	103.52	90.99	85.28	—
	21.90%	25.40%	23.60%	26.30%	26.20%	26.10%	—
	9.10%	12.60%	11.60%	14.60%	12.60%	13.70%	—
	—	3.50%	—	4.40%	—	3.90%	—
	18.20%	18.70%	—	—	—	—	—
	-14.50%	8.70%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,558	1,500	1,262	—
	40.14	42.37	28.68	—
	1,344	1,277	1,033	—
	0.00	0.00	0.00	—
	307.76	299.14	232.92	—
	269.07	256.32	214.50	—
	37.26	32.66	10.55	—
	92.86	87.64	56.98	—
	648.05	612.94	520.32	—
	254.13	265.32	257.70	—
	-6.40	0.00	0.00	—
	247.73	265.32	257.70	—
	61.49	66.25	64.20	—
	186.25	199.07	193.50	—
	28.62	29.59	29.47	—
Key metrics
	377.85	385.62	325.23	—
	24.26%	25.70%	25.80%	—
	11.96%	13.30%	15.30%	—
	—	13.80%	15.30%	—
	—	18.90%	—	—
	—	2.90%	—	—
	—	-234.14	-67.43	—
	—	1.34	1.31	—
	—	0.33	0.24	—
	—	453.77	-42.60	—
	—	4.4	-10.7	—
Balance sheet
	—	2,383	1,905	—
	—	684.90	687.05	—
	—	54.76	368.32	—
	—	75.54	41.89	—
	—	38.34	24.10	—
	—	14.20	17.75	—
	—	1,376	972.85	—
	—	95.54	102.91	—
	—	226.57	152.43	—
	—	508.53	325.72	—
	—	7.63	3.97	—
	—	500.90	321.75	—
	—	1,544	1,356	—
Cash flow
	—	267.71	253.30	—
	—	-441.93	-208.62	—
	—	136.47	300.63	—
	—	501.85	320.73	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	328.49	312.42	291.40	315.82	277.94	273.91	—
	10.64	8.95	9.16	11.31	12.88	6.95	—
	289.01	256.98	235.25	256.64	230.07	219.08	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	58.89	59.72	56.83	55.93	51.13	49.49	—
	56.95	51.74	48.27	48.45	47.39	44.14	—
	8.12	4.22	2.65	2.96	3.00	4.00	—
	21.57	18.47	16.82	16.68	16.67	13.38	—
	142.74	127.04	115.91	133.14	112.25	106.54	—
	50.11	64.39	65.31	70.48	60.75	61.78	—
	0.00	0.00	-5.54	0.00	0.00	0.00	—
	50.11	64.39	59.76	70.48	60.75	61.78	—
	12.92	16.34	15.48	15.88	17.46	17.33	—
	37.19	48.05	44.28	54.60	43.29	44.45	—
	5.67	7.51	6.75	8.33	6.60	6.78	—
Key metrics
	79.80	87.08	79.23	90.12	80.42	79.16	—
	24.30%	27.90%	27.20%	28.50%	28.90%	28.90%	—
	11.30%	15.40%	15.20%	17.30%	15.60%	16.20%	—
	—	3.50%	—	4.40%	—	4.10%	—
	18.20%	14.10%	—	—	—	—	—
	-14.10%	8.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,248	1,198	1,060	—
	40.06	42.25	28.14	—
	1,038	978.95	841.79	—
	0.00	0.00	0.00	—
	231.37	223.62	192.59	—
	205.41	195.85	177.22	—
	17.95	12.84	8.61	—
	73.54	68.63	42.41	—
	518.83	488.35	422.37	—
	250.29	260.93	246.34	—
	-5.54	0.00	0.00	—
	244.74	260.93	246.34	—
	60.62	65.16	61.64	—
	184.12	195.77	184.70	—
	28.26	29.19	28.17	—
Key metrics
	336.23	342.40	297.36	—
	26.94%	28.60%	28.10%	—
	14.75%	16.30%	17.40%	—
	—	13.90%	16.00%	—
	—	13.00%	—	—
	—	6.00%	—	—
	—	-252.34	-60.53	—
	—	1.18	1.19	—
	—	0.16	0.05	—
	—	223.60	-292.41	—
	—	7.1	-9.4	—
Balance sheet
	—	2,160	1,710	—
	—	671.92	665.88	—
	—	37.43	367.41	—
	—	67.14	36.56	—
	—	28.51	18.17	—
	—	10.39	8.74	—
	—	1,115	708.87	—
	—	72.65	82.16	—
	—	185.03	121.57	—
	—	261.03	75.00	—
	—	2.62	0.75	—
	—	258.41	74.25	—
	—	1,608	1,423	—
Cash flow
	—	230.85	219.88	—
	—	-423.40	-173.29	—
	—	145.44	301.84	—
	—	483.19	280.41	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 40.90%

Holder	Type	Holding	Previous	Change
AJAY PRATAP THAKKER	Promoter	20.74%	—	—
WESTERN MEDICAL SOLUTIONS LLP	Promoter	8.70%	—	—
SBI HEALTHCARE OPPORTUNITIES FUND	Public	7.77%	—	—
ANKIT AJAY THAKKER	Promoter	6.67%	—	—
JM FINANCIAL PRODUCTS LIMITED	Public	3.42%	—	—
GOLDMAN SACHS FUNDS -GOLDMAN SACHSINDIA EQUITY P	Public	2.75%	—	—
MIHIR WIRE INDUSTRIES PVT LTD	Public	2.15%	—	—
NEETA DEVANG GANDHI	Promoter Group	2.10%	—	—
KIRTIKA AJAY THAKKER	Promoter Group	2.03%	—	—
SBI LIFE INSURANCE CO. LTD	Public	2.01%	—	—
DR NAVIN RAMJI DAVDA	Public	2.00%	—	—
JM FINANCIAL AND INVESTMENT CONSULTANCY SERVICES	Public	1.91%	—	—
RAMAKANT JAGDISH TIBREWALA	Public	1.87%	—	—
NITIN MANILAL THAKKER	Public	1.86%	—	—
MAHESH RAMAKANT TIBREWALA	Public	1.80%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.15 Sep 2026 · Company Update / Analyst / Investor Meet
Q1 FY27 Earnings Conference Call - Transcript7 Aug 2026 · Company Update / Earnings Call Transcript
Intimation of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30,2026.3 Aug 2026 · Company Update / Newspaper Publication
Audio Link of Analyst/ Investor Conference Call for Q1 FY273 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation under Regulation 30(5) of the Listing Regulation31 Jul 2026 · Company Update / General
Investor Presentation for the quarter ended June 30, 202631 Jul 2026 · Company Update / Investor Presentation
Acquistion of shares31 Jul 2026 · Company Update / Acquisition
Change in Managment31 Jul 2026 · Company Update / Change in Management
Outcome of Board Meeting dated July 31, 202631 Jul 2026 · Result / Financial Results
Outcome of Board Meeting dated July 31, 202631 Jul 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd30 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd29 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Earnings Conference Call - Q1 FY 2727 Jul 2026 · Company Update / Analyst / Investor Meet
Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Unaudited Financial ....27 Jul 2026 · Board Meeting / Board Meeting
Voting Results and Scrutinizer's Report of the 24th Annual General Meeting of the Company17 Jul 2026 · AGM/EGM / AGM
We refer to our intimation dated May 15, 2026, and June 22, 2026, regarding the sub-division/split of the existing equity shares of the Company. In this regard, we wish to inform you that, ....17 Jul 2026 · Corp. Action / Record Date
Proceedings of the 24th Annual General Meeting of the Company (for detailed proceedings please refer the attached pdf)17 Jul 2026 · AGM/EGM / AGM
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 20266 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Letter to Shareholders- Weblink of AGM Notice and Annual Report29 Jun 2026 · Company Update / General
Intimation of Newspaper Advertisement for the 24th Annual General Meeting of the Company to be held on Friday, July 17, 2026, through Video Conference (VC') /Other Audio-Visual Means ('OAVM').25 Jun 2026 · Company Update / Newspaper Publication
Intimation of Closure of Trading Window.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Annual Report 2025-2624 Jun 2026 · Others / Reg. 34 (1) Annual Report
Annual Report 2025-2624 Jun 2026 · Others / Reg. 34 (1) Annual Report
Business Responsibility and Sustainability Report for the Financial year 2025-26.22 Jun 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of the 24th Annual General Meeting of the Company will be held on Friday, July 17, 2026 at 11:00 A.M. IST through Video Conferencing/ Other Audio Visual Means ('VC/ OAVM')22 Jun 2026 · AGM/EGM / AGM
Intimation of Newspaper Publication of the 24th Annual General Meeting of the Company to be held on Friday, July 17, 2026 through Video Conference ('VC') /Other Audio-Visual Means ('OAVM').19 Jun 2026 · Company Update / Newspaper Publication
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.3 Jun 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.3 Jun 2026 · Company Update / Analyst / Investor Meet
Q4 & FY 26 Earnings Conference Call - Transcript21 May 2026 · Company Update / Earnings Call Transcript
Annual Secretarial Conpliance report for the year ended March 31, 202618 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')- Resignation Letter of Dr. Bhaskar18 May 2026 · Company Update / Resignation of Director
Audio Link of Analyst /Investor Conference call for Q4 & FY 2618 May 2026 · Company Update / Analyst / Investor Meet
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')- Resignation of Chief Financial Officer18 May 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
Newspaper Publication for Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 202617 May 2026 · Company Update / Newspaper Publication
InvInvestor Presentation for the quarter and year ended March 31, 2026estor Presentation15 May 2026 · Company Update / Investor Presentation
Considered and approved Sub- Division/Stock Split of the equity shares of the Company15 May 2026 · Corp. Action / Sub-division / Stock Split
Record Date for Declaration of Interim Dividend15 May 2026 · Corp. Action / Record Date
Intimation under Regulation 30 of the Listing Regulation15 May 2026 · Company Update / Change in Management
Outcome of Board Meeting dated May 15, 2026, for detailed disclosure please refer the PDF15 May 2026 · Result / Financial Results
Outcome of Board Meeting dated May 15, 2026, please refer the attached PDF for detailed information15 May 2026 · Board Meeting / Outcome of Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Stock Split From Rs.10/- to Rs.2/-	24 Jul 2026	24 Jul 2026	—
Interim Dividend - Rs. - 1.0000	22 May 2026	22 May 2026	—
Final Dividend - Rs. - 1.0000	4 Jul 2025	4 Jul 2025	—
Final Dividend - Rs. - 1.0000	2 Aug 2024	2 Aug 2024	—

Board meetings

31 Jul 2026 Board Meeting - Financial Results